Is DSIP Legal? Global Status Guide
Category: Sleep · Tracked in 159 countries
29
Legal1
Research Only123
Grey Area3
Prescription3
BannedCan You Buy DSIP?
Whether you can buy DSIP depends on your country. It is legal to purchase in 29 countries, including Barbados, Anguilla, Antigua and Barbuda, Aruba, Bosnia and Herzegovina, British Virgin Islands, Bahamas, Cayman Islands, and 21 more. A prescription is required in 3 countries, including Australia, New Zealand, United Arab Emirates. It falls into a legal grey area in 123 countries (Algeria, Andorra, Angola, Argentina, Belgium, Belize, Bolivia, Bonaire, and 115 more), where it may be available for research but not for human use. It is banned in 3 countries: Cuba, Saudi Arabia, Singapore.
Traveling with DSIP
Traveling internationally with DSIP requires understanding local laws at your destination. Do not carry DSIP into countries where it is banned (Cuba, Saudi Arabia, Singapore) — you could face serious legal consequences. In countries requiring a prescription (Australia, New Zealand, United Arab Emirates), carry a valid prescription or doctor's letter. Always declare pharmaceutical products at customs and check the latest regulations before traveling.
Need to calculate your DSIP dosage? Use the DSIP reconstitution calculator on peptide.locker
DSIP Legal Status by Country (159)
| Country | Status | Rx Required | Schedule | Detail |
|---|---|---|---|---|
| Anguilla | Legal | No | Not Scheduled | — |
| Antigua and Barbuda | Legal | No | Not Scheduled | — |
| Aruba | Legal | No | Not Scheduled | — |
| Bahamas | Legal | No | Not Scheduled | — |
| Barbados | Legal | No | Not Scheduled | — |
| Bosnia and Herzegovina | Legal | No | Not Scheduled | — |
| British Virgin Islands | Legal | No | Not Scheduled | — |
| Cayman Islands | Legal | No | Not Scheduled | — |
| Costa Rica | Legal | No | Not Scheduled | — |
| Curacao | Legal | No | Not Scheduled | — |
| Dominica | Legal | No | Not Scheduled | — |
| Dominican Republic | Legal | No | Not Scheduled | — |
| Georgia | Legal | No | Not Scheduled | — |
| Grenada | Legal | No | Not Scheduled | — |
| Jamaica | Legal | No | Not Scheduled | — |
| Montenegro | Legal | No | Not Scheduled | — |
| Montserrat | Legal | No | Not Scheduled | — |
| North Macedonia | Legal | No | Not Scheduled | — |
| Papua New Guinea | Legal | No | Not Scheduled | — |
| Samoa | Legal | No | Not Scheduled | — |
| Serbia | Legal | No | Not Scheduled | — |
| St Kitts and Nevis | Legal | No | Not Scheduled | — |
| St Lucia | Legal | No | Not Scheduled | — |
| St Vincent and the Grenadines | Legal | No | Not Scheduled | — |
| Tonga | Legal | No | Not Scheduled | — |
| Trinidad and Tobago | Legal | No | Not Scheduled | — |
| Turks and Caicos | Legal | No | Not Scheduled | — |
| Ukraine | Legal | No | Not Scheduled | — |
| Vanuatu | Legal | No | Not Scheduled | — |
| United Kingdom | Research Only | No | Not Scheduled | Not a controlled substance under Misuse of Drugs Act 1971. No MHRA marketing authorisation. Legal to buy/possess for research. Illegal to sell for human consumption. |
| Algeria | Grey Area | No | Unregistered | — |
| Andorra | Grey Area | No | Not Scheduled / Unauthorized | — |
| Angola | Grey Area | No | Unregistered | — |
| Argentina | Grey Area | No | Unregistered | — |
| Austria | Grey Area | No | Not Scheduled / Unauthorized | — |
| Bahrain | Grey Area | No | Unregistered | — |
| Bangladesh | Grey Area | No | Not Scheduled | — |
| Belgium | Grey Area | No | Not Scheduled / Unauthorized | — |
| Belize | Grey Area | No | Unregistered | — |
| Bolivia | Grey Area | No | Unregistered | — |
| Bonaire | Grey Area | No | Unregistered | — |
| Botswana | Grey Area | No | Unregistered | — |
| Brazil | Grey Area | No | Unregistered | Not ANVISA-approved. No registered pharmaceutical product. |
| Brunei | Grey Area | No | Not Scheduled | — |
| Bulgaria | Grey Area | No | Not Scheduled / Unauthorized | — |
| Cambodia | Grey Area | No | Not Scheduled | — |
| Cameroon | Grey Area | No | Unregistered | — |
| Canada | Grey Area | No | Unauthorized Medicine | Unauthorized drug per Health Canada. Not scheduled under CDSA. Possession not criminal but sale/import for human use is illegal. |
| Cape Verde | Grey Area | No | Unregistered | — |
| Chile | Grey Area | No | Unregistered | — |
| China | Grey Area | No | Not Scheduled | Not NMPA-approved. Strict domestic regulation of unapproved pharmaceuticals. |
| Colombia | Grey Area | No | Unregistered | — |
| Croatia | Grey Area | No | Not Scheduled / Unauthorized | — |
| Cyprus | Grey Area | No | Not Scheduled / Unauthorized | — |
| Czech Republic | Grey Area | No | Not Scheduled / Unauthorized | — |
| Democratic Republic of Congo | Grey Area | No | Unregistered | — |
| Denmark | Grey Area | No | Not Scheduled / Unauthorized | — |
| Ecuador | Grey Area | No | Unregistered | — |
| Egypt | Grey Area | No | Unregistered | — |
| El Salvador | Grey Area | No | Unregistered | — |
| Estonia | Grey Area | No | Not Scheduled / Unauthorized | — |
| Ethiopia | Grey Area | No | Unregistered | — |
| Fiji | Grey Area | No | Not Scheduled | — |
| Finland | Grey Area | No | Not Scheduled / Unauthorized | — |
| France | Grey Area | No | Not Scheduled / Unauthorized | — |
| French Guiana | Grey Area | No | Unregistered | — |
| Germany | Grey Area | No | Not Scheduled / Unauthorized | Unauthorized medicinal product under AMG. Not listed in AntiDopG Annexes. Import triggers prosecution under pharmaceutical law. |
| Ghana | Grey Area | No | Unregistered | — |
| Greece | Grey Area | No | Not Scheduled / Unauthorized | — |
| Guatemala | Grey Area | No | Unregistered | — |
| Guyana | Grey Area | No | Unregistered | — |
| Honduras | Grey Area | No | Unregistered | — |
| Hong Kong | Grey Area | No | Not Scheduled | — |
| Hungary | Grey Area | No | Not Scheduled / Unauthorized | — |
| Iceland | Grey Area | No | Not Scheduled / Unauthorized | — |
| India | Grey Area | No | Not Scheduled | Not CDSCO-approved. No specific regulation. Available through chemical suppliers. |
| Indonesia | Grey Area | No | Not Scheduled | — |
| Iran | Grey Area | No | Unregistered | — |
| Iraq | Grey Area | No | Unregistered | — |
| Ireland | Grey Area | No | Not Scheduled / Unauthorized | — |
| Israel | Grey Area | No | Unregistered | — |
| Italy | Grey Area | No | Not Scheduled / Unauthorized | — |
| Ivory Coast | Grey Area | No | Unregistered | — |
| Japan | Grey Area | No | Not Scheduled | Not PMDA-approved. No specific scheduling. Strict pharmaceutical regulations apply. |
| Jordan | Grey Area | No | Unregistered | — |
| Kenya | Grey Area | No | Unregistered | — |
| Kuwait | Grey Area | No | Unregistered | — |
| Laos | Grey Area | No | Not Scheduled | — |
| Latvia | Grey Area | No | Not Scheduled / Unauthorized | — |
| Lebanon | Grey Area | No | Unregistered | — |
| Libya | Grey Area | No | Unregistered | — |
| Liechtenstein | Grey Area | No | Not Scheduled / Unauthorized | — |
| Lithuania | Grey Area | No | Not Scheduled / Unauthorized | — |
| Luxembourg | Grey Area | No | Not Scheduled / Unauthorized | — |
| Madagascar | Grey Area | No | Unregistered | — |
| Malawi | Grey Area | No | Unregistered | — |
| Malaysia | Grey Area | No | Not Scheduled | — |
| Maldives | Grey Area | No | Not Scheduled | — |
| Malta | Grey Area | No | Not Scheduled / Unauthorized | — |
| Mauritius | Grey Area | No | Unregistered | — |
| Mexico | Grey Area | No | Unregistered | Not COFEPRIS-approved. Available through grey-market channels. |
| Monaco | Grey Area | No | Not Scheduled / Unauthorized | — |
| Morocco | Grey Area | No | Unregistered | — |
| Mozambique | Grey Area | No | Unregistered | — |
| Myanmar | Grey Area | No | Not Scheduled | — |
| Namibia | Grey Area | No | Unregistered | — |
| Nepal | Grey Area | No | Not Scheduled | — |
| Netherlands | Grey Area | No | Not Scheduled / Unauthorized | — |
| Nicaragua | Grey Area | No | Unregistered | — |
| Nigeria | Grey Area | No | Unregistered | — |
| Norway | Grey Area | No | Not Scheduled / Unauthorized | — |
| Oman | Grey Area | No | Unregistered | — |
| Pakistan | Grey Area | No | Not Scheduled | — |
| Panama | Grey Area | No | Unregistered | — |
| Paraguay | Grey Area | No | Unregistered | — |
| Peru | Grey Area | No | Unregistered | — |
| Philippines | Grey Area | No | Not Scheduled | — |
| Poland | Grey Area | No | Not Scheduled / Unauthorized | — |
| Portugal | Grey Area | No | Not Scheduled / Unauthorized | — |
| Puerto Rico | Grey Area | No | Unregistered | — |
| Qatar | Grey Area | No | Unregistered | — |
| Romania | Grey Area | No | Not Scheduled / Unauthorized | — |
| Russia | Grey Area | No | Not Scheduled | Not a registered pharmaceutical in Russia despite Russian origin research. |
| Rwanda | Grey Area | No | Unregistered | — |
| Saba | Grey Area | No | Unregistered | — |
| Saint Barthelemy | Grey Area | No | Unregistered | — |
| Saint Martin (French) | Grey Area | No | Unregistered | — |
| Senegal | Grey Area | No | Unregistered | — |
| Seychelles | Grey Area | No | Unregistered | — |
| Sint Eustatius | Grey Area | No | Unregistered | — |
| Sint Maarten | Grey Area | No | Unregistered | — |
| Slovakia | Grey Area | No | Not Scheduled / Unauthorized | — |
| Slovenia | Grey Area | No | Not Scheduled / Unauthorized | — |
| South Africa | Grey Area | No | Unregistered | — |
| South Korea | Grey Area | No | Not Scheduled | — |
| Spain | Grey Area | No | Not Scheduled / Unauthorized | — |
| Sri Lanka | Grey Area | No | Not Scheduled | — |
| Suriname | Grey Area | No | Unregistered | — |
| Sweden | Grey Area | No | Not Scheduled / Unauthorized | — |
| Switzerland | Grey Area | No | Not Scheduled / Unauthorized | — |
| Taiwan | Grey Area | No | Not Scheduled | — |
| Tanzania | Grey Area | No | Unregistered | — |
| Thailand | Grey Area | No | Not Scheduled | — |
| Tunisia | Grey Area | No | Unregistered | — |
| Turkey | Grey Area | No | Not Scheduled / Unauthorized | — |
| Uganda | Grey Area | No | Unregistered | — |
| United States | Grey Area | No | Not Scheduled | Not FDA-approved. Was on FDA Category 2 (do-not-compound) list. HHS Secretary RFK Jr. announced Feb 2026 reclassification to Category 1 (pending formal publication). Not a controlled substance. Sold as research chemical. |
| Uruguay | Grey Area | No | Unregistered | — |
| US Virgin Islands | Grey Area | No | Unregistered | — |
| Venezuela | Grey Area | No | Unregistered | — |
| Vietnam | Grey Area | No | Not Scheduled | — |
| Zambia | Grey Area | No | Unregistered | — |
| Zimbabwe | Grey Area | No | Unregistered | — |
| Australia | Prescription | Yes | Schedule 4 | Not TGA-approved. Classified as Schedule 4 (Prescription Only Medicine) as a pharmacologically active injectable peptide. Import without valid prescription or research permit is illegal. |
| New Zealand | Prescription | Yes | Unapproved (Rx Required) | Not Medsafe-approved. Prescription required for unapproved medicines. |
| United Arab Emirates | Prescription | Yes | Unapproved (Rx Required) | — |
| Cuba | Banned | No | State Controlled | State-controlled pharmaceutical system. Unapproved medicines prohibited. |
| Saudi Arabia | Banned | No | State Controlled | Strict pharmaceutical controls. Unapproved injectable peptides prohibited. |
| Singapore | Banned | No | State Controlled | Strict pharmaceutical controls. Unapproved medicines prohibited. |
Data is researcher-verified but not legal advice. Regulations change frequently. Always verify with local authorities before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.